<unk>  is used in the management of hyperphosphatemia in adult patients with stage 4 and 5 chronic kidney disease (CKD) on hemodialysis. Its efficacy at lowering phosphate levels is similar to that of calcium acetate, but without the accompanying risk of hypercalcemia and arterial calcification. In patients with CKD, it has also been shown to reduce LDL and cholesterol.
Sevelamer
Etofibrate
Tirofiban
Ganirelix
Rosuvastatin
Cetrorelix
Lovastatin
Fenofibrate